Anti-inflammatory pharmaceutical formulations
AssigneeNorton Healthcare Limited
InventorsAusten John Woolfe, Siobhan Greene, Gordon McIntyre, Nitin Vadilal Sheth
Life of this patent
Estimating the term…
Abstract
An oral pharmaceutical dosage form including a mixture of a delay release formulation of a non-steroidal anti-inflammatory drug (NSAID) and a mixture containing a prostaqlandin and one or more excipients.
Claims16
An oral pharmaceutical dosage form, comprising a hard gelatin capsule filled with a mixture of a delay release formulation of a non-steroidal anti-inflammatory drug (NSAID) and a mixture containing a prostaglandin and one or more excipients, wherein the prostaglandin mixture is a powder and the dosage form contains multi-particulate coated particles selected from the group consisting of beads and granules of the NSAID formulation together with the powdered prostaglandin mixture.
An oral pharmaceutical dosage form, comprising a bi-layer or tri-layer tablet with a mixture of a delay release formulation of a non-steroidal anti-flammatory drug (NSAID) and a mixture containing a prostaglandin and one or more excipients, wherein the prostaglandin mixture is a powder and the dosage form contains multi-particulate coated particles selected from the group consisting of beads and granules of the NSAID formulation together with the powdered prostaglandin mixture.
Dependencies are inferred from the claim text.